1 MONTELUKAST SODIUM | 60 of 160 | 1120 prescriptions Less than 1% of all prescriptions | 380 | 290 patients 30% of all patients | 130 patients 14% of all patients | |
2 FLUTICASONE PROPIONATE | 60 of 150 | 910 prescriptions Less than 1% of all prescriptions | 280 | 220 patients 23% of all patients | < 11 | |
3 AZELASTINE HCL | 50 of 130 | 610 prescriptions Less than 1% of all prescriptions | 250 | 200 patients 21% of all patients | < 11 | |
4 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 30 of 130 | 590 prescriptions Less than 1% of all prescriptions | 360 | 130 patients 14% of all patients | < 11 | |
5 FLOVENT HFA (FLUTICASONE PROPIONATE) | 20 of 110 | 380 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
6 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 50 of 140 | 310 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 60 of 90 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 GAMMAGARD LIQUID (IMMUN GLOB G(IGG)/GLY/IGA OV50) | 10 | 300 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
9 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 30 of 60 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 VENTOLIN HFA (ALBUTEROL SULFATE) | 60 of 120 | 330 prescriptions Less than 1% of all prescriptions | 130 | 190 patients 20% of all patients | < 11 | |
11 DESLORATADINE | 10 | 170 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
12 PREDNISONE | 30 of 90 | 300 prescriptions Less than 1% of all prescriptions | | 170 patients 18% of all patients | < 11 | |
13 ALVESCO (CICLESONIDE) | 10 of 20 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 PROAIR HFA (ALBUTEROL SULFATE) | 60 of 90 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 XOLAIR (OMALIZUMAB) | 40 of 50 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |